Mesoblast (MESO) Net Cash Flow (2016 - 2023)

Mesoblast has disclosed Net Cash Flow across 8 years of filings, most recently posting -$110.3 million for Q2 2023.

• Net Cash Flow for Q2 2023 came in at -$110.3 million, up 6.3% year-over-year; the trailing twelve-month figure through Dec 2024 was -$110.3 million (down 42.17% YoY), and the FY2025 annual result was $97.5 million, up 1273.74% from the prior year.
• Net Cash Flow came in at -$110.3 million for Q2 2023 at Mesoblast, down from $16.2 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $139.2 million in Q1 2021 to a low of -$182.6 million in Q2 2021.
• The 5-year median for Net Cash Flow is $7.8 million (2019), against an average of -$21.9 million.
• Across the five-year window, Net Cash Flow tumbled 2399.25% in 2020 and surged 599.61% in 2021, its largest moves.
• Mesoblast's Net Cash Flow stood at $1.3 million in 2019, then sank by 2399.25% to -$30.6 million in 2020, then soared by 40.42% to -$18.2 million in 2021, then jumped by 190.31% to $16.5 million in 2022, then slumped by 770.11% to -$110.3 million in 2023.
• The last three Net Cash Flow figures came in at -$110.3 million (Q2 2023), $16.2 million (Q1 2023), and $16.5 million (Q4 2022), per Business Quant data.